ghk-cu dosage per kg or weight based Does Really Work? 40 Years of Research Reviewed GHK-Cu Peptide: What It Does

8 weeks: ~4 vials 12 weeks: ~6 vials 16 weeks: ~8 vials Insulin Syringes (U-100, 1 mL) Per injection: 1 syringe 8 weeks (5-on/2-off): ~40 syringes 16 weeks: ~80 syringes Bacteriostatic Water (10 mL bottles) Use 2.03.0 mL per 10 mg vial for reconstitution

Liver damage can lead to a decrease in GSH concentration in erythrocytes

Evidence boundary No large Western randomized controlled trial of Pinealon has been published

Ongoing low-dose maintenance (experimental) Continuous dosing approach: Dose: 1-2mg daily OR 3-5mg 2-3x weekly Duration: Ongoing (not cycled) Goal: Maintain constant telomerase activation Status: Experimental, not from research protocols Rationale: Telomerase needs continuous activation to maintain telomere length Cyclic dosing may allow regression between cycles Low-dose continuous might provide stable benefits Similar to maintenance protocols for other peptides Continuous dosing options: Advantages of continuous: No "off" periods where benefits regress Potentially stronger cumulative anti-aging More like natural physiologic regulation Easier to stack with other peptides Disadvantages: Much higher annual cost ($1,800-3,600 vs $300-600) No long-term safety data Uncertain if better than cyclic approach Storage challenges (more reconstitution) Deviates from proven protocols Current recommendation: Stick with proven 10-day cycles for most users Consider continuous only if cyclic approach inadequate Start with standard protocol first Assess your individual response Consult with peptide-knowledgeable physician Use our peptide cycle planning guide to design your Epithalon protocol

Safety first: Always use a sterile needle dont touch it